Weight loss drugs may help obese teens have less suicidal thoughts, study finds
A new study found that obese teens prescribed with weight loss drugs are less likely to have suicidal thoughts.
The FDA issued a warning about compounding pharmacies on weight-loss drugs
A surge of alternatives to newly popular weight-loss drugs is facing its biggest test yet after the FDA warned companies against skirting regulatory standards to put them on the market now that shortages are waning.
FDA says shortage of popular diabetes, weight-loss drugs resolved
The FDA says the shortage of tirzepatide injection — a glucagon-like peptide 1 medication used for diabetes and weight loss — has been resolved.
Eli Lilly’s weight-loss and diabetes drugs are no longer in shortage, says FDA
The U.S. Food and Drug Administration said Eli Lilly’s diabetes and weight-loss drugs marketed as Zepbound and Mounjaro are no longer in shortage signaling that the company has succeeded in expanding manufacturing.
Lilly's weight-loss drug removed from FDA's shortage list
The U.S. Food and Drug Administration removed Eli Lilly's blockbuster weight-loss and diabetes drugs from its shortage list late on Wednesday, likely piling pressure on firms selling cheaper versions known as compounded drugs.
Eli Lilly’s weight-loss drug no longer in shortage, FDA says
Eli Lilly’s (NYSE:LLY) blockbuster GLP-1 medication, tirzepatide, is no longer in shortage in the U.S., the U.S. Food and Drug Administration (FDA) said on Wednesday. Tirzepatide, currently marketed by Eli Lilly (LLY) as Mounjaro and Zepbound for diabetes and weight loss,
Weight-loss jabs ‘important for economy so people get back into work’, says PM
New weight-loss jabs could help boost the economy in Britain by getting people “back into work”, the Prime Minister has said.
tyla20h
Doctor issues devastating warning of ‘overlooked’ side effects of using Ozempic
Wylie said: "Ozempic (semaglutide) is a medication licensed for the management of type 2 diabetes. While it has shown ...
News Medical on MSN7h
Dietitians boost GLP-1 therapy success with personalized care and side effect management
Researchers reveal the importance of personalized communication and side effect management in improving outcomes for patients ...
ahajournals.org4d
Muscle Mass and Glucagon-Like Peptide-1 Receptor Agonists: Adaptive or Maladaptive Response to Weight Loss?
Recent studies have shown that pharmacologic weight loss with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and combination therapies is approaching magnitudes achieved with surgery. However, ...
i40m
Am I eligible for a weight loss jab? Mounjaro to help get unemployed back to work
Patients will first be eligible to receive the drug if they have a BMI over 40 and at least three of specified weight-related ...
News Medical on MSN9h
Semaglutide enhances cognitive abilities and reduces Alzheimer’s pathology in mice and human brain models
Researchers find that Semaglutide improves cognitive function and reduces amyloid and tau pathology in Alzheimer's disease ...
Gynecologist Reveals Ozempic's 'Unexpected' Effects on Your Vagina
"Their effects on vaginal health are an important consideration that is often overlooked," gynecologist Melanie Bone told Newsweek.
NBC DFW5d
Surging demand leaves many without crucial diabetes and ADHD medications
Ozempic is in a class of medication called GLP-1, or glucagon-like peptide 1, agonists, which are primarily used to ...
studyfinds17h
Study: Obese teens taking popular weight loss drugs less likely to consider suicide
Drugs like Ozempic and Wegovy may provide a surprising, life-saving benefit for the youngest patients taking these diabetes and weight loss medications.
Modern Healthcare4d
This is what buyers of digital health solutions want in a partner
Most digital health purchasers plan to increase their investments next year and are asking for risk-based contracts.
Weight-loss jab 'important for economy so people can get back into work', says PM
The Prime Minister said the anti-obesity medication could help people "get back into work" and reduce pressure on the NHS, ...